Related Experiment Video
Updated: May 7, 2026

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro
Published on: December 5, 2025
The mechanisms linking adiposopathy to type 2 diabetes
Jichun Yang1, Jihong Kang, Youfei Guan
1Department of Physiology and Pathophysiology, Peking University Diabetes Center, Peking University Health Science Center, Beijing, 100191, China.
Adiposopathy, a deregulated adipose tissue function, drives type 2 diabetes through lipotoxicity and cytokine toxicity. This impacts pancreatic beta cells and liver insulin resistance, highlighting obesity
Area of Science:
- Metabolic disorders
- Endocrinology
- Obesity research
Background:
- Obesity is characterized by excessive body fat accumulation.
- Adiposopathy, or deregulated adipose tissue function, is a significant risk factor for various diseases, including diabetes and cardiovascular conditions.
- Hyperlipidemia in obese individuals with adiposopathy leads to lipotoxicity in pancreatic islets and the liver, causing pancreatic beta cell dysfunction and hepatic insulin resistance, key drivers of type 2 diabetes.
Purpose of the Study:
- To review the latest findings on how adiposopathy-related lipotoxicity and cytokine toxicity contribute to the development of type 2 diabetes.
- To elucidate the role of adipokines in glucose homeostasis and their dysregulation in adiposopathy.
Main Methods:
- Literature review of recent research on adiposopathy, lipotoxicity, cytokine toxicity, and type 2 diabetes.
- Analysis of the impact of altered adipokine profiles on pancreatic beta cell function and insulin resistance.
Main Results:
- Adiposopathy-induced lipotoxicity and cytokine toxicity are critical in the pathogenesis of type 2 diabetes.
- Dysfunctional adipokines associated with adiposopathy correlate with pancreatic beta cell dysfunction and peripheral insulin resistance.
- Hyperlipidemia in adiposopathy contributes to beta cell dysfunction and liver insulin resistance.
Conclusions:
- Adiposopathy is a central factor in type 2 diabetes development through metabolic insults.
- Understanding adipokine dysregulation in adiposopathy is crucial for therapeutic strategies.
- Lipotoxicity and cytokine toxicity stemming from adiposopathy are key mechanisms driving type 2 diabetes.
More Related Videos
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Type 2 and Gestational

